Learning Objective 1: describe the relationship between severity of alcohol withdrawal symptoms and choice of pharmacological therapy for AWS.
Learning Objective 2: identify the theoretical structures used in this evidence based implementation process to facilitate translating evidence into practice.
Evidence shows that when a standardized tool to guide assessment and treatment is employed by nurses, the target outcome for most patients is a safe course of withdrawal. A nurse managed protocol was developed by a multidisciplinary team based on best available evidence. The revised Clinical Institute Withdrawal Assessment for Alcohol scale (CIWA-Ar) (Sullivan, Sykora, Schneiderman, Naranjo, & Sellers, 1989) was chosen to quantify alcohol withdrawal symptoms when patients were able to participate. The protocol provided decision support for the choice of an appropriate setting and medication regimen for management of symptoms. The dose and frequency of a short acting benzodiazepine was based on the the assessed severity of symptoms and guided the frequency of patient re-assessment with the CIWA-Ar scale by nursing staff. Patients’ safe passage through risky illness like AWS depends upon health care providers using the best available evidence.